Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation

Lisa C. Martial*, Karin E. J. Hoogtanders, Michiel F. Schreuder, Elisabeth A. Cornelissen, Jac van der Heijden, Manuela A. Joore, Erik M. van Maarseveen, David M. Burger, Sander Croes, Roger J. M. Bruggemann, Rob E. Aarnoutse

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)412-421
Number of pages10
JournalTherapeutic Drug Monitoring
Volume39
Issue number4
DOIs
Publication statusPublished - Aug 2017

Keywords

  • tacrolimus
  • mycophenolic acid
  • TDM
  • DBS acceptability
  • pediatric KTx
  • TANDEM MASS-SPECTROMETRY
  • RENAL-TRANSPLANT PATIENTS
  • LC-MS/MS
  • CYCLOSPORINE-A
  • PLASMA SPOTS
  • QUANTITATIVE-ANALYSIS
  • WHOLE-BLOOD
  • HEMATOCRIT
  • SIROLIMUS
  • IMMUNOSUPPRESSANTS

Cite this

Martial, L. C., Hoogtanders, K. E. J., Schreuder, M. F., Cornelissen, E. A., van der Heijden, J., Joore, M. A., van Maarseveen, E. M., Burger, D. M., Croes, S., Bruggemann, R. J. M., & Aarnoutse, R. E. (2017). Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation. Therapeutic Drug Monitoring, 39(4), 412-421. https://doi.org/10.1097/FTD.0000000000000422